{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Completeness of cytoreduction will be estimated and recorded using a complete cytoreduction (CC) which corresponds to a residual disease (RR) score. Completeness of Cytoreduction (CC) scores range from CC0 - CC3 and correlate to residual disease as follows:\n\nCC0 = R0: No Disease, complete removal of all visible tumor with negative cytology or microscopic margin CC1 = R1: \\<= 0.25 cm; complete removal of all visible tumor with positive cytology or microscopic margin CC2 = R2a: 0.25-2.5 cm; minimal residual tumor, nodule(s) ≤ 0.5 cm CC3 =R2b: \\>=2.5 cm; gross residual tumor, nodule(s), \\> 0.5, but ≤ 2 cm CC3 =R2c: \\>=2.5 cm; extensive disease remaining, nodule(s) \\> 2 cm","groups":[{"description":"HIPEC + 40mg of Mitomycin C. Mitomycin C, 30 mg, were administered into the inflow line of the perfusion circuit once target temperature was reached. At the 60 minute time point of the perfusion, Mitomycin C, 10 mg, was administered into the inflow line of the perfusion circuit. Once the 90-minute perfusion period had elapsed, the perfusate was drained into the waste reservoir. The peritoneal cavity was rinsed/washed-out.\n\nHIPEC\n\nMitomycin C","id":"OG000","title":"HIPEC + Mitomycin C"}],"populationDescription":"Data was not collected and therefore Completeness of Cytoreduction was never able to be estimated.","reportingStatus":"POSTED","timeFrame":"Up through study discontinuation or 12 months after study treatment, whichever occurs first","title":"Completeness of Cytoreduction","type":"PRIMARY"}